Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery CD7

Path Created with Sketch.
Go to CD7 Normal Tissue GalleryGo back to Product Page
Adrenal gland - Adrenal cortical adenoma containing few CD7 positive T-lymphocytes.
Adrenal gland – Adrenal cortical adenoma containing few CD7 positive T-lymphocytes.
Kidney - Clear cell renal cell carcinoma containing a moderate number of CD7 positive T-lymphocytes.
Kidney – Clear cell renal cell carcinoma containing a moderate number of CD7 positive T-lymphocytes.
Kidney - Papillary renal cell carcinoma (type I) with a focal infiltrate of CD7 positive T-lymphocytes.
Kidney – Papillary renal cell carcinoma (type I) with a focal infiltrate of CD7 positive T-lymphocytes.
Lymph node - B-cell chronic lymphatic leukemia with intermingled CD7 positive T-cells.
Lymph node – B-cell chronic lymphatic leukemia with intermingled CD7 positive T-cells.
Lymph node - Diffuse large B-cell lymphoma with intermingled CD7 positive T-cells.
Lymph node – Diffuse large B-cell lymphoma with intermingled CD7 positive T-cells.
Lymph node - Follicular B-cell lymphoma containing a large number of CD7 positive T-lymphocytes.
Lymph node – Follicular B-cell lymphoma containing a large number of CD7 positive T-lymphocytes.
Lymph node - Large cell anaplastic T-cell lymphoma with strong CD7 expression of tumor cells.
Lymph node – Large cell anaplastic T-cell lymphoma with strong CD7 expression of tumor cells.
Lymph node - Lymphoblastic T-cell lymphoma with strong CD7 expression of all tumor cells.
Lymph node – Lymphoblastic T-cell lymphoma with strong CD7 expression of all tumor cells.
Oral cavity - Squamous cell carcinoma showing a dense infiltrate of CD7 positive T-lymphocytes.
Oral cavity – Squamous cell carcinoma showing a dense infiltrate of CD7 positive T-lymphocytes.
Ovary - Endometroid carcinoma showing a diffuse weak to moderate membranous CD7 positivity of tumor cells.
Ovary – Endometroid carcinoma showing a diffuse weak to moderate membranous CD7 positivity of tumor cells.
Pancreas - Neuroendocrine tumor exhibiting a dense infiltrate of CD7 positive T-lymphocytes in the stroma.
Pancreas – Neuroendocrine tumor exhibiting a dense infiltrate of CD7 positive T-lymphocytes in the stroma.
Parotid gland - Warthin tumor exhibiting a dense infiltrate of CD7 positive T-lymphocytes.
Parotid gland – Warthin tumor exhibiting a dense infiltrate of CD7 positive T-lymphocytes.
Skin - Malignant melanoma containing few CD7 positive T-lymphocytes.
Skin – Malignant melanoma containing few CD7 positive T-lymphocytes.
Stomach - Gastric adenocarcinoma (intestinal type) with a focal, moderate to strong, predominantly membranous CD7 positivity of cancer cells.
Stomach – Gastric adenocarcinoma (intestinal type) with a focal, moderate to strong, predominantly membranous CD7 positivity of cancer cells.
Stomach - Gastrointestinal stromal tumor (GIST) containing few CD7 positive T-lymphocytes.
Stomach – Gastrointestinal stromal tumor (GIST) containing few CD7 positive T-lymphocytes.
Testis - Seminoma containing a significant number of CD7 positive T-lymphocytes.
Testis – Seminoma containing a significant number of CD7 positive T-lymphocytes.
Urinary bladder - Muscle-invasive urothelial carcinoma containing a moderate number of CD7 positive T-lymphocytes.
Urinary bladder – Muscle-invasive urothelial carcinoma containing a moderate number of CD7 positive T-lymphocytes.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors